| Date Filed | Type | Description |
| 10/04/2023 |
4
| Huber Martin H. Jr. (President, CEO) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 9,102 options to buy
@ $1.26, valued at
$11.5k
|
|
| 08/18/2023 |
4
| Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 136,500 options to buy
@ $2.785, valued at
$380.2k
|
|
| 07/06/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 4,477 options to buy
@ $3.42, valued at
$15.3k
|
|
| 06/12/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 14,467 shares
@ $0
Granted 18,355 options to buy
@ $8.64, valued at
$158.6k
|
|
| 04/05/2023 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 3,375 options to buy
@ $4.25, valued at
$14.3k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 136,500 options to buy
@ $2.69, valued at
$367.2k
|
|
| 06/23/2022 |
4/A
| Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.28, valued at
$45.6k
|
|
| 06/17/2022 |
4
| Huber Martin H. Jr. (PRESIDENT AND HEAD OF R&D) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.28, valued at
$45.6k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Huber Martin H. Jr. (PRESIDENT OF R&D AND CMO) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $12.66, valued at
$822.9k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 10,185 options to buy
@ $6.44, valued at
$65.6k
|
|
| 10/25/2021 |
4
| Huber Martin H. Jr. (President of R&D and CMO) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 157,058 options to buy
@ $16, valued at
$2.5M
|
|
| 10/21/2021 |
3
| Huber Martin H. Jr. (President of R&D and CMO) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Huber Martin H. Jr. (Director) has filed a Form 4 on Mersana Therapeutics, Inc.|
Txns:
| Granted 48,096 options to buy
@ $8.57, valued at
$412.2k
|
|
| 06/24/2020 |
3
| Huber Martin H. Jr. (Director) has filed a Form 3 on Mersana Therapeutics, Inc. |
| 01/22/2019 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Unknown transaction of 12,206 shares
@ $75, valued at
$915.5k
Disposed/sold 1,250 restricted stock units
@ $0
Disposed/sold 8,750 restricted stock units
@ $0
Disposed/sold 4,447 restricted stock units
@ $0
Disposed/sold 22,727 restricted stock units
@ $0
Disposed/sold 75,000 options to buy
@ $55.14, valued at
$4.1M
Disposed/sold 35,000 options to buy
@ $43.39, valued at
$1.5M
Disposed/sold 10,782 options to buy
@ $178.95, valued at
$1.9M
Disposed/sold 39,942 options to buy
@ $55.84, valued at
$2.2M
|
|
| 09/25/2018 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Sold 371 shares
@ $37.63, valued at
$14k
Exercised 1,250 restricted stock units
@ $0 |
|
| 03/05/2018 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Sold 1,803 shares
@ $54.86, valued at
$98.9k
Exercised 4,375 restricted stock units
@ $0
Exercised 1,483 restricted stock units
@ $0
Granted 22,727 restricted stock units
@ $0
Granted 39,942 options to buy
@ $55.84, valued at
$2.2M
|
|
| 12/05/2017 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Sold 829 shares
@ $85.24, valued at
$70.7k
Exercised 1,750 restricted stock units
@ $0 |
|
| 11/20/2017 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 1,750 restricted stock units
@ $0 |
|
| 09/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2017 |
4
| Huber Martin H. Jr. (SVP & Cheif Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Sold 829 shares
@ $153.02, valued at
$126.9k
Exercised 1,750 restricted stock units
@ $0 |
|
| 03/29/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/03/2016 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 1,000 shares
@ $0
Sold 327 shares
@ $121.29, valued at
$39.7k
|
|
| 09/23/2016 |
4
| Huber Martin H. Jr. (SVP & Chief Medical Officer) has filed a Form 4 on TESARO, Inc.|
Txns:
| Sold 408 shares
@ $108.12, valued at
$44.1k
Exercised 1,250 restricted stock units
@ $0 |
|